Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 19 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research

Fee For Service(FFS)

Full Time Equivalent(FTE)

Medicinal Chemistry

Synthetic Chemistry

Analytical Chemistry

Biology Research

Structural Biology

Cell Biology

Computational Biology & Molecular Modeling

Enzymology & Molecular Interactions

Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
APIs

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Preformulation Study

Formulation Technology Research

Preparation Quality Research

Laboratory-scale Preparation Testing

Pilot-scale Preparation Testing

GMP-based Clinical Sample Production & Packaging

Formulation Stability Study

Consistency Evaluation

Analytical Method Development and Quality Control
CMC Filings
03 Preclinical Research
Pharmacology & Pharmacodynamics

Tumor Models

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

Toxicokinetics

Pharmacokinetics

In Vitro Pharmacokinetic Assays

In Vivo Pharmacokinetic Assays

Bioanalysis

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

IND Filings
01 One-stop Integrated Services
Pharmaceutical Research Platform
Drug Discovery Plarform
One-stop API Process R&D Department
Translational Medicine Platform
Pharmaceutical Research CDMO Service Platform
Chemical Drug Development
Medicilon's CDMO Service Platform
Preclinical Research Services
02 Key Technical Services for Drug R&D
Process Department Solid Form Screening Platform
SEND Format Conversion Platform
Flow Cytometry Technology Platform
Safety Assessment Lab of Process Chemistry
Drug Forming Research Platform
Metabolite Identification (MetID) Service Platform
Cytokine and Biomarker Detection Platform
03 Innovative Drug Services
Nucleic Acid Drug R&D Platform
Non-clinical Research for Cellular Immunotherapies
mRNA Vaccine Bioanalysis Platform
PROTAC Drug Discovery Research Platform
ADC R&D Service Platform
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System
Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases
IO Pharmacodynamic Model Evaluation Platform
05 Advanced Preparation R&D
Skin Topical Preparation R&D
Ophthalmic drug R&D platform
Inhalation drug R&D platform
06 Drug Analysis
07 Public Services
CLIENT CENTER
Intellectual Property Protection
Downloads
Partnerships
Newsletters
U.S.

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2023-03-20Market Events
Join Medicilon at SAPA-GP 2023 Annual Conference

Date: 3.31-4.1 2023

Location: King of Prussia, Pennsylvania

Learn more
2023-03-14Market Events
Join Medicilon at BioTrinity 2023: Catalysing Growth in the Life Sciences Industry

Date: April 25-26, 2023

Location: Etc. venues 155 Bishopsgate, London

Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CAREERS
Talent Development
Employee Activities
Campus Recruitment
Social Recruitment
Campus Recruitment
Campus Recruitment
Social Recruitment
Social Recruitment
Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global Clinical Research Organizations in 2021| Top 10 Global CDMO Enterprises| Preclinical Drug Development Process
Sep 13,2022
CDMO is Coming a Good Choice
CDMO, Contract development and manufacturing organization, mainly provides process development and preparation, process optimization, registration and validation batch production and commercialized and customized R&D and production services for pharmaceutical manufacturers and biotechnology companies, especially innovative products organizations.
More
CDMO is Coming a Good Choice
Sep 09,2022
Domestic and Global Market of ADC Drugs
ADC drugs​ are mainly used in the field of anti-tumor, which is one of the hot research directions in recent years. ADC is composed of three parts: monoclonal antibody (mAb), coupling chain (linker) and cytotoxic small molecule (cytotoxin/payload). tumor lesions.
More
Domestic and Global Market of ADC Drugs
Sep 09,2022
ADC Drug Research Report
The design idea of ADC drugs is to couple antibodies with cytotoxic drugs, so as to simultaneously exert the high specificity of antibodies and the high toxicity of cytotoxic small molecules.
More
ADC Drug Research Report
Sep 08,2022
Birth, Development and Prospect of ADC Drugs
ADC (antibody-conjugated drug) is not a new concept. As the early 20th century, the Nobel Prize winner in medicine, German scientist Paul Ehrlich, had proposed the concept of ADC and called ADC drugs " Magic Bullet". But it wasn't until the 1950s that research on ADC drugs took off.
More
Birth, Development and Prospect of ADC Drugs
Sep 07,2022
HER2 ADC Terminator?
If there were pharmaceutical companies involved in making PD-1 antibodies before 2012, they might have become companies with a valuation of tens of billions by now.
More
HER2 ADC Terminator?
Sep 06,2022
The ADC drug industry is thriving!
Medicilon has rich experience in developing and validating analysis methods for different targets, and can effectively analyze the expression level and accessibility of targets according to needs, and provide constructive suggestions for target selection.
More
The ADC drug industry is thriving!
Sep 02,2022
ALK inhibitors: iterative upgrade, targeted therapies strike with precision
Fourth-generation ALK inhibitors are currently under investigation. Biomedical technology is constantly advancing and drug development is constantly evolving. Medicilon has established a one-stop platform for preclinical biopharmaceutical R&D services, including drug discovery, pharmacological research, and preclinical research.
More
ALK inhibitors: iterative upgrade, targeted therapies strike with precision
Aug 30,2022
ADC drug interpretation (4) | ADC market situation and competitive landscape
In recent years, the global ADC drug R&D and investment has been escalating. With the advancement of technology, ADC has not only broken through the classic antibody + linker + small molecule toxin model in structure, but also become a new type of ADC drugs.
More
ADC drug interpretation (4) | ADC market situation and competitive landscape
Aug 29,2022
Interpretation of ADC drugs (3) | An article to analyze the difficulties of ADC drug development
The complex and diverse structure of ADC drugs, as well as the complexities of in vivo actions and metabolic processes, bring multiple challenges to CMC research and preclinical research.
More
Interpretation of ADC drugs (3) | An article to analyze the difficulties of ADC drug development
Aug 26,2022
What is the subtleties of Antibody-drug conjugates
Antibody-drug conjugates (ADCs) have been the focus of tumor therapy research in recent years. The mechanism of action of ADC is complex and usually requires drug internalization followed by intracellular processing and payload release.
More
What is the subtleties of Antibody-drug conjugates
Stock Code
688202

Global

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880(U.S. - West Coast)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 24, Seochojungang-ro 8-gril, Seocho-gu, Seoul, 06643 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->